Efficacy and Safety of Long-term Treatment with Lurasidone in Older Adults with Bipolar Depression: Results of a 6 Month Open-label Study

被引：1
|
作者：
Forester, Brent [1 ,2 ]
Sajatovic, Martha [3 ]
Tsai, Joyce [4 ,5 ]
Kroger, Hans [4 ,5 ]
Pikalov, Andrei [4 ,5 ]
Cucchiaro, Josephine [4 ,5 ]
Loebel, Antony [4 ,5 ]
机构：
[1] Harvard Univ, Sch Med, Boston, MA USA
[2] McLean Hosp, Belmont, MA 02178 USA
[3] Case Western Reserve Univ, Sch Med, Cleveland, OH USA
[4] Sunov Pharmaceut Inc, Marlborough, MA USA
[5] Sunov Pharmaceut Inc, Ft Lee, NJ USA
来源：
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY | 2015年 / 23卷 / 03期
关键词：
D O I：
10.1016/j.jagp.2014.12.178
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
NR 25
引用
收藏
页码：S170 / S171
页数：3
相关论文
共 50 条
  • [31] Long-term safety and efficacy of zafirlukast in the treatment of asthma: interim results of an open-label extension trial
    Grossman, J
    Smith, LJ
    Wilson, AM
    Thyrum, PT
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1999, 82 (04) : 361 - 369
  • [32] Lurasidone dosing in a 6-month open label long term extension study
    Liang, S.
    Pikalov, A.
    Zhao, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 40 : S324 - S324
  • [33] Switching to Lurasidone following 12 months of treatment with Risperidone: results of a 6-month, open-label study
    Greg W. Mattingly
    Peter M. Haddad
    Michael Tocco
    Jane Xu
    Debra Phillips
    Andrei Pikalov
    Antony Loebel
    BMC Psychiatry, 20
  • [34] Switching to Lurasidone following 12 months of treatment with Risperidone: results of a 6-month, open-label study
    Mattingly, Greg W.
    Haddad, Peter M.
    Tocco, Michael
    Xu, Jane
    Phillips, Debra
    Pikalov, Andrei
    Loebel, Antony
    BMC PSYCHIATRY, 2020, 20 (01)
  • [35] Long-term Safety and Efficacy of Etanercept in Patients With Psoriasis: An Open-label Study
    Leonardi, Craig
    Strober, Bruce
    Gottlieb, Alice B.
    Elewski, Boni E.
    Ortonne, Jean-Paul
    van de Kerkhof, Peter
    Chiou, Chiun-Fang
    Dunn, Meleana
    Jahreis, Angelika
    JOURNAL OF DRUGS IN DERMATOLOGY, 2010, 9 (08) : 928 - 937
  • [36] Long-term efficacy and safety with zonisamide: Interim analysis of an open-label study
    Wroe, S
    Brodie, MJ
    EPILEPSIA, 2005, 46 : 118 - 118
  • [37] Long-Term Safety and Efficacy of Anifrolumab in Adults With Systemic Lupus Erythematosus: Results of a Phase II Open-Label Extension Study
    Chatham, W. Winn
    Furie, Richard
    Saxena, Amit
    Brohawn, Philip
    Schwetje, Erik
    Abreu, Gabriel
    Tummala, Raj
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 (05) : 837 - 847
  • [38] ABP 501 Long-Term Safety/Efficacy: Interim Results from an Open-Label Extension Study
    Cohen, Stanley
    Pablos, Jose L.
    Zhang, Nan
    Rizzo, Warren
    Muller, Gerhard
    Padmanaban, Devi
    Kivitz, Alan
    Matsumoto, Alan K.
    Kaur, Primal
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [39] Long-Term Safety and Efficacy of Olokizumab in Patients with Rheumatoid Arthritis - Results of an Open-Label Extension Study
    Feist, Eugen
    Nasonov, Evgeny
    Luggen, Michael
    Fatenejad, Saeed
    Grishin, Sergey
    Samsonov, Mikhail
    Fleischmann, Roy
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 603 - 606
  • [40] LONG-TERM EFFICACY AND SAFETY OF LANADELUMAB: FINAL RESULTS FROM THE HELP OPEN-LABEL EXTENSION STUDY
    Banerji, A.
    Hao, J.
    Yu, M.
    Bernstein, J.
    Johnston, D.
    Riedl, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S21 - S21
12345